The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke

European Journal of Neurology

Volumn 19, Issue 4, 2012, Pages 570-577

  Choi, K H ^a,b   Park, M S ^c,d   Kim, J T ^b,c   Nam, T S ^a   Choi, S M ^c   Kim, B C ^c   Kim, M K ^c   Cho, K H ^b  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

Ferritin; Hemorrhagic transformation; Iron; Ischaemic stroke

Indexed keywords

FERRITIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMORRHAGIC TRANSFORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FERRITINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858334270     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03564.x     Document Type: Article

References (30)

1. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke 2007; 38: 75-79.
2. Lesnefsky EJ. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv Exp Med Biol 1994; 366: 129-146.
3. Connor JR, Menzies SL, St Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 1990; 27: 595-611.
4. Birgegard G, Hogman C, Killander A, Wide L. Serum ferritin levels in male blood donors: relation to number of phlebotomies and iron supplementation. Vox Sang 1978; 34: 65-70.
5. Herbert V, Jayatilleke E, Shaw S, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells 1997; 15: 291-296.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
7. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008; 39: 1647-1652.
8. Armengou A, Davalos A, Fernandez-Real JM, Castillo J. Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke 1998; 29: 258-260.
9. Erdemoglu AK, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol 2002; 9: 633-637.
10. Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 2004; 35: 147-150.
11. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251.
12. Castellanos M, Leira R, Serena J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003; 34: 40-46.
13. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59: 669-674.
14. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997; 28: 957-960.
15. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
16. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007; 24: 1-10.
17. Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction - a prospective study. Stroke 1986; 17: 179-185.
18. Millan M, Sobrino T, Castellanos M, et al. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke 2007; 38: 90-95.
19. Davalos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology 2000; 54: 1568-1574.
20. Perez de la Ossa N, Sobrino T, Silva Y, et al. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 2010; 41: 810-813.
21. Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 2003; 28: 229-244.
22. Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 2004; 3: 345-353.
23. Castellanos M, Puig N, Carbonell T, et al. Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats. Brain Res 2002; 952: 1-6.
24. Patt A, Horesh IR, Berger EM, Harken AH, Repine JE. Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. J Pediatr Surg 1990; 25: 224-227; discussion 227-228.
25. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26: 770-772.
26. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992; 12: 417-427.
27. Sorond FA, Ratan RR. Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2000; 2: 421-436.
28. Bishop GM, Robinson SR. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 2001; 907: 175-187.
29. Day SM, Duquaine D, Mundada LV, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003; 107: 2601-2606.
30. Araujo JA, Romano EL, Brito BE, et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995; 15: 1172-1180.